title: Sweet syndrome: acute febrile neutrophilic dermatosis.
abstract: Sweet, in 1964, described a skin condition characterized by fever, leukocytosis, tender erythematous plaques, and, histopathologically, a predominantly neutrophilic dermal inflammation. However, other dermatologic conditions can present with similar clinical and histological features. Therefore, diagnostic criteria are important for the correct diagnosis. Use of systemic steroids is the treatment of choice for Sweet syndrome. A number of other medications can be useful at times, such as potassium iodide, dapsone, indomethacin, and colchicine.
authors.affiliation: Department of Dermatology, Mayo Clinic, Rochester, MN 55905, USA.
authors.forename: W P
authors.initials: WP
authors.lastname: Su
authors.forename: D L
authors.initials: DL
authors.lastname: Fett
authors.forename: L E
authors.initials: LE
authors.lastname: Gibson
authors.forename: M R
authors.initials: MR
authors.lastname: Pittelkow
mesh_terms: D003937:Diagnosis, Differential; D006801:Humans; D012867:Skin / Q000473:pathology; D016463:Sweet Syndrome / Q000150:complications / Q000175:diagnosis / Q000473:pathology / Q000628:therapy